Concord Drugs (BOM:538965) 3-Year Book Growth Rate : 8.20% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Concord Drugs 3-Year Book Growth Rate?

Concord Drugs's Book Value per Share for the quarter that ended in Dec. 2023 was ₹0.00.

During the past 12 months, Concord Drugs's average Book Value per Share Growth Rate was 8.30% per year. During the past 3 years, the average Book Value per Share Growth Rate was 8.20% per year. During the past 5 years, the average Book Value per Share Growth Rate was 6.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 10 years, the highest 3-Year average Book Value per Share Growth Rate of Concord Drugs was 12.30% per year. The lowest was 0.80% per year. And the median was 7.90% per year.

Competitive Comparison of Concord Drugs's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Concord Drugs's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Concord Drugs's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Concord Drugs's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Concord Drugs's 3-Year Book Growth Rate falls into.

Concord Drugs 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Concord Drugs (BOM:538965) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Concord Drugs 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Concord Drugs's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Drugs (BOM:538965) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Concord Drugs Ltd (BOM:538965) » Definitions » 3-Year Book Growth Rate

Traded in Other Exchanges

N/A

Address

3-11-451, L B Nagar, Hayatnagar Mandal, Hyderabad, TG, IND, 500074

Website

https://www.concorddrugs.in

Concord Drugs Ltd is an India based pharmaceutical company. The principal activity of the company is to manufacture licensed drugs based on the formulations approved. Its product portfolio includes Pharmaceutical Ready to fill Pellets, MUPS ((Multiple Unit Pellets System); Tissue Bio Adhesive; Injectables (Small Volume Parenterals); Capsules; Liquid Orals (Syrups & Suspensions); Dry Syrups (Powder) and Hand Sanitizers. Geographically, it operates only in India.

Concord Drugs (BOM:538965) Headlines

No Headlines